Hemophilia, a single gene defect disorder, is the most prevalent inherited bleeding disorder (due to clotting factor deficiency) with an occurrence of 1 in 10000 births. In untreated patients or patients with sub-optimal treatment, it progresses to chronic disability and premature mortality. However, in suitable cases, management can be done in a home setting. Home-based therapy lets early access to clotting factors and, hence, immediate treatment resulting in decreased pain, dysfunction, and long-term disability and significantly decreased hospital admissions for complications.
To elaborate on the home-therapy setting of hemophilia, Takeda and Docplexus have organized an interactive LIVE webinar on 29th July 2020, Wednesday, 5 PM onwards. Join our expert, Dr. N. Vijaya Kumar who will be discussing “Home Based Therapy & Its Shreds Of Evidence In Hemophilia Management” – The way forward…
